Technical Analysis for GANX - Gain Therapeutics, Inc.

Grade Last Price % Change Price Change
F 8.3 -6.21% -0.55
GANX closed down 6.21 percent on Tuesday, July 27, 2021, on 1.79 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical GANX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week Low Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
New 52 Week Closing Low Bearish -6.21%
Narrow Range Bar Range Contraction -6.21%
Older End-of-Day Signals for GANX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 9 hours ago
Down 2 ATRs about 12 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Down 5% about 13 hours ago
Down 3% about 13 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gain Therapeutics, Inc., a development stage biotechnology company, develops novel therapeutics to treat rare genetic and neurological disorders caused by protein misfolding in Switzerland and Spain. The company through its in-licensed proprietary Site-Directed Enzyme Enhancement Therapy platform, discovers novel allosteric sites on misfolded proteins, identifies proprietary binding sites, and restores protein folding. It has a research collaboration agreement with Sumitomo Dainippon Pharma Co., Ltd. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was founded in 2017 and is based in Bethesda, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Allosteric Regulation Sumitomo Group

Is GANX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.93
52 Week Low 7.64
Average Volume 27,057
200-Day Moving Average 0.00
50-Day Moving Average 9.86
20-Day Moving Average 9.53
10-Day Moving Average 9.09
Average True Range 0.58
ADX 32.27
+DI 8.95
-DI 39.71
Chandelier Exit (Long, 3 ATRs) 9.04
Chandelier Exit (Short, 3 ATRs) 9.37
Upper Bollinger Bands 10.57
Lower Bollinger Band 8.50
Percent B (%b) -0.1
BandWidth 21.70
MACD Line -0.35
MACD Signal Line -0.25
MACD Histogram -0.0954
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.16
Resistance 3 (R3) 10.15 9.51 9.85
Resistance 2 (R2) 9.51 9.04 9.52 9.75
Resistance 1 (R1) 8.91 8.75 8.59 8.92 9.64
Pivot Point 8.27 8.27 8.12 8.28 8.27
Support 1 (S1) 7.67 7.80 7.35 7.68 6.96
Support 2 (S2) 7.03 7.51 7.04 6.85
Support 3 (S3) 6.43 7.03 6.75
Support 4 (S4) 6.44